malondialdehyde has been researched along with Huntington Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Feligioni, M; Fotoohi, A; Hassanzadeh, K; Hosseini, S; Izadpanah, E; Moloudi, MR | 1 |
| Abdel Moneim, AE; Abdelfattah, MS; Aref, AM; Attia, GH; Badr, SEA; Kassab, RB; Lotfy, SA | 1 |
| Kalia, AN; Kaur, M; Prakash, A | 1 |
| Borrero-Sánchez, J; Cabrera-Rivero, A; Castillo-Casañas, Y; Esteban-Hernández, EM; Fernández-Almirall, I; Fernández-Carriera, R; González-García, S; González-Quevedo, A; Guerra-Badía, R; Hernández-Díaz, Z; Lara-Fernández, G; Martínez-Bonne, O; Menéndez-Sainz, MC; Peña-Sánchez, M; Pérez-López, C; Riverón-Forment, G; Soto-Lavastida, A; Valdés-Ramos, L; Zaldívar-Vaillant, T | 1 |
| Beal, MF; Calingasan, NY; Cormier, K; Ferrante, RJ; Smith, K; Wille, EJ; Yang, L | 1 |
| Galván-Arzate, S; Maldonado, PD; Molina-Jijón, E; Pedraza-Chaverrí, J; Santamaría, A; Villeda-Hernández, J | 1 |
| Christofides, J; Darlington, LG; Egerton, M; Forrest, CM; Mackay, GM; Stone, TW; Stoy, N | 1 |
| Chen, CM; Cheng, ML; Chiu, DT; Lee, PW; Lee, YM; Liu, JL; Soong, BW; Wu, YR | 1 |
| Alam, ZI; Halliwell, B; Jenner, P | 1 |
9 other study(ies) available for malondialdehyde and Huntington Disease
| Article | Year |
|---|---|
A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington's Disease.
Topics: Animals; Antioxidants; Behavior, Animal; Body Weight; Catalase; Cerebral Cortex; Cyclohexenes; Glutathione; Huntington Disease; Locomotion; Male; Malondialdehyde; Mastication; Neuroprotective Agents; Nitro Compounds; Propionates; Rats, Wistar; Rotarod Performance Test; Superoxide Dismutase; Terpenes | 2021 |
Rutin and Selenium Co-administration Reverse 3-Nitropropionic Acid-Induced Neurochemical and Molecular Impairments in a Mouse Model of Huntington's Disease.
Topics: Animals; bcl-2-Associated X Protein; Brain-Derived Neurotrophic Factor; Caspase 3; Catalase; Corpus Striatum; Down-Regulation; Drug Synergism; Glial Fibrillary Acidic Protein; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Huntington Disease; Interleukin-1beta; Male; Malondialdehyde; Mice; Neuroprotective Agents; Nitric Oxide; Nitro Compounds; Oxidative Stress; Peroxidase; Propionates; Proto-Oncogene Proteins c-bcl-2; Rutin; Selenium; Superoxide Dismutase; Synaptic Transmission; Tumor Necrosis Factor-alpha; Up-Regulation | 2020 |
Neuroprotective potential of antioxidant potent fractions from Convolvulus pluricaulis Chois. in 3-nitropropionic acid challenged rats.
Topics: Animals; Antioxidants; Behavior, Animal; Body Weight; Convolvulus; Corpus Striatum; Glutathione; Huntington Disease; Lipid Peroxidation; Male; Malondialdehyde; Neuroprotective Agents; Neurotoxicity Syndromes; Nitrites; Nitro Compounds; Propionates; Rats; Rats, Wistar; Superoxide Dismutase | 2016 |
Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease.
Topics: Adult; Age Factors; Age of Onset; Aged; Antioxidants; Biomarkers; Case-Control Studies; Catalase; Caudate Nucleus; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glycation End Products, Advanced; Humans; Huntington Disease; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Sulfhydryl Compounds; Superoxide Dismutase; Tomography, X-Ray Computed | 2015 |
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8-Hydroxy-2'-Deoxyguanosine; alpha-Synuclein; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Creatine; Deoxyguanosine; Disease Models, Animal; Dopamine; Drug Therapy, Combination; Glutathione; Glutathione Disulfide; Huntington Disease; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitro Compounds; Parkinson Disease; Propionates; Rats; Rats, Inbred Lew; Tyrosine 3-Monooxygenase; Ubiquinone | 2009 |
NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington's disease in rats: protective role of apocynin.
Topics: Acetophenones; Animals; Corpus Striatum; Disease Models, Animal; Huntington Disease; Lipid Peroxidation; Male; Malondialdehyde; Motor Activity; NADPH Oxidases; Neuroprotective Agents; Nitric Oxide Synthase; Protein Carbonylation; Quinolinic Acid; Rats; Rats, Wistar; Superoxides; Time Factors; Xanthine Oxidase | 2010 |
Tryptophan metabolism and oxidative stress in patients with Huntington's disease.
Topics: Adolescent; Adult; Aged; Aldehydes; Brain; Female; Humans; Huntington Disease; Kynurenine; Male; Malondialdehyde; Middle Aged; Neopterin; Nerve Growth Factors; Oxidative Stress; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Tryptophan | 2005 |
Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Biomarkers; Deoxyguanosine; DNA, Mitochondrial; Erythrocytes; Female; Humans; Huntington Disease; Male; Malondialdehyde; Middle Aged; Mitochondria; Oxidative Stress; Superoxide Dismutase | 2007 |
No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease.
Topics: Adult; Aged; Brain; Caudate Nucleus; DNA; Female; Frontal Lobe; Gas Chromatography-Mass Spectrometry; Humans; Huntington Disease; Lipid Metabolism; Male; Malondialdehyde; Middle Aged; Nerve Tissue Proteins; Oxidative Stress; Putamen; Reference Values; Thiobarbituric Acid Reactive Substances | 2000 |